UFC middleweight Ricardo Abreu has been notified by the United States Anti-Doping Agency of a potential anti-doping violation stemming from an out-of-competition sample collected on Dec. 21.
Abreu is already serving two-year suspension from USADA after testing positive for 19-norandrosterone (19-NA) above the decision limit of 3 ng/mL and 19-noretiocholanolone in an out-of-competition test on June 3. Both substances are metabolites of the anabolic steroid nandrolone. Under the terms of his current suspension, Abreu is not eligible to return to competition until July 1, 2018.
USADA will handle the results management and potential punishment regarding Abreu’s latest positive test. The Brazilian will be entitled to a full legal review process before any sanctions are imposed.
The 32-year-old Brazilian last appeared at UFC Fight Night 68 in June 2015, when he dropped a split decision against Jake Collier. Abreu is 5-1 over the course of his professional career, which includes a win over Wagner Silva Gomes in his Octagon debut at “The Ultimate Fighter: Brazil 3” finale.